IE
ARRY

Israel Englander’s Array Biopharma Inc ARRY Stock Holding History

Israel Englander’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-300,000
Closed -$2.51M – 4075
2017
Q2 		$2.51M Buy
300,000
+270,000
+900% +$2.21M ﹤0.01% 1940
2017
Q1 		$268K Buy
+30,000
New +$319K ﹤0.01% 3092

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Israel Englander's ARRY Position: Q3 2019 in Review

Israel Englander sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,021,920 shares — an estimated $140M sold.

Israel Englander first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $140M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Israel Englander reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Israel Englander sold 3,021,920 Array Biopharma Inc shares in Q3 2019, an estimated $140M.
  • Israel Englander first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Israel Englander's Array Biopharma Inc position peaked at $140M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.